- Mini Review
- Open access
- Published:
Central blood pressure: A new vital sign?
Artery Research volume 3, pages 125–127 (2009)
References
Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MSV, et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009;119:2408–16.
Kelly R, Hayward C, Ganis J, Daley J, Avolio A, O’Rourke M. Noninvasive registration of the arterial pressure waveform using high-fidelity applanation tonometry. J Vasc Med Biol 1989;1:142–9.
Chen C-H, Ting CT, Nussbacher A, Nevo E, Kass DA, Pak P, et al. Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure. Hypertension 1996;27:168–75.
Pauca AL, O’Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001;38:932–7.
Siebenhofer A, Kemp CRW, Sutton AJ, Williams B. The reproducibility of central aortic blood pressure measurements in healthy subjects using applanation tonometry and sphygmocardiography. J Hum Hypertens 1999;13:625–9.
Lane D, Beevers M, Barnes N, Bourne J, John A, Malins S, et al. Inter-arm differences in blood pressure: when are they clinically significant? J Hypertens 2002;20:1089–95.
Lee ET, Welty TK, Fabsitz RR, Cowan LD, Lee N-A, Oopik AJ, et al. The Strong Heart Study: a study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol 1990;132:1141–55.
Fox CS, Coady S, Sorlie PD, D’Agostino Sr RB, Pencina MJ, Ramachandran RS, et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation 2007;115:1544–50.
Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 2007;50:197–203.
Roman MJ, Okin PM, Kizer JR, Lee ET, Howard BV, Devereux RB. Relations of central and brachial blood pressure to left ventricular hypertrophy and geometry: the Strong Heart Study. J Hypertens, in press.
de Simone G, Kizer JR, Chinali M, Roman MJ, Bella JN, Best LG, et al. Normalization for body size and the population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. Am J Hypertens 2005;18:191–6.
de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH. Effect of growth on variability of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995;25:1056–62.
Chen C-H, Ting C-T, Lin S-J, His T-L, Ho S-J, Chou P, et al. Which arterial and cardiac parameters best predict left ventricular mass? Circulation 1998;98:422–8.
Flack JM, Gardin JM, Yunis C for the CARDIA Research Group. Static and pulsatile blood pressure correlates of left ventricular structure and function in black and white young adults: the Cardia Study. Am Heart J 1999;138:856–64.
Verdecchia P, Schillaci G, Borgioni C, Gaatobigio R, Ambrosio G, Porcellati C. Prevalent influence of systolic over pulse pressure on left ventricular mass in essential hypertension. Eur Heart J 2002;23:658–65.
Wang K-L, Cheng H-M, Chuang S-Y, Spurgeon HA, Ting C-T, Lakatta EG, et al. Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality? J Hypertens 2009;27:461–7.
Pini R, Cavallini MC, Palmieri V, Marchionni N, Di Bari M, Devereux RB, et al. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. J Am Coll Cardiol 2008;51: 2432–9.
Roman MJ, Devereux RB, Kizer JR, Okin PM, Lee ET, Wang W. High central pulse pressure is independently associated with adverse cardiovascular outcome: the Strong Heart Study. J Am Coll Cardiol 2009;54:1730–4.
Roman MJ, Devereux RB, Kizer JR, Okin PM, Lee ET, Wang W. High central pulse pressure is independently associated with adverse cardiovascular outcome: the Strong Heart Study. J Am Coll Cardiol, 2009; 54:1730–4.
De Luca N, Asmar RG, London GM, O’Rourke MF, Safar on behalf of the REASON Project Investigators. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens 2004;22:1623–30.
Poulter NR, Weddel H, Dahlof B, Sever PS, Beevers DG, Caulfield M, et al. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the anglo-scandinavian cardiac outcomes trial-blood pressure lowering arm (ASCOT-BPLA). Lancet 2005;366:907–13.
The CAFÉ Investigatorsfor the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Investigators. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Principal results of the conduit artery function evaluation (CAFÉ) study. Circulation 2006;113: 1213–25.
Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359:995–1003.
McEniery CBM, Yasmin McDonnell B, Munnery M, Wallace SM, Rowe CV, et al on Behalf of the Anglo-Cardiff Collaborative Trial Investigators. Central pressure: variability and impact of cardiovascular risk factors: the anglo-cardiff collaborative trial II. Hypertension 2008;51:1476–82.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This is an open access article distributed under the CC BY-NC license. https://doi.org/creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Roman, M.J. Central blood pressure: A new vital sign?. Artery Res 3, 125–127 (2009). https://doi.org/10.1016/j.artres.2009.10.179
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.artres.2009.10.179